The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Bacteremia caused by hemolytic, high-level gentamicin-resistant Enterococcus faecalis
Open accessAbstract
Between 1 January 1984 and 31 December 1987, 206 enterococcal blood isolates at the University of Wisconsin Hospital and Clinics were analyzed for high-level aminoglycoside resistance (hereafter high-level aminoglycoside resistance is simply referred to as "resistance") and hemolysin production. Of 190 Enterococcus faecalis isolates, 68 (35.8%) were resistant to gentamicin. Of these 68 strains, 67 (98.5%) contained a gene coding for the bifunctional aminoglycoside-modifying 6'-aminoglycoside acetyltransferase-2"-aminoglycoside phosphotransferase [AAC(6')-APH(2")] enzyme. Of 190 isolates, 85 (44.7%) were hemolytic and contained a gene coding for component A of the enterococcal hemolysin. Sixty-two of 68 (91.2%) gentamicin-resistant isolates but only 23 of 122 (18.8%) gentamicin-susceptible isolates were hemolytic (P less than 0.001). Twelve of the hemolytic, gentamicin-resistant E. faecalis blood isolates, but only 2 of 9 nonhemolytic or gentamicin-susceptible isolates, had identical chromosomal DNA restriction endonuclease digestion patterns, suggesting a common derivation for these strains. A historical cohort study from 1 July 1985 to 31 March 1987 identified by regression analysis postsurgical intensive care unit status (odds ratio [OR], 5.0; 95% confidence interval [CI], 1.1 to 22.8) and prior treatment with an expanded- or broad-spectrum cephalosporin (OR, 3.0; 95% CI, 0.9 to 10.1) as risk factors for gentamicin-resistant E. faecalis bacteremia. Patients with hemolytic, gentamicin-resistant E. faecalis bacteremia had a fivefold-increased risk for death within 3 weeks of their bacteremia compared with patients with nonhemolytic, gentamicin-susceptible strains (95% CI, 1.0 to 25.4).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
A rapid alkaline extraction procedure for screening recombinant plasmid DNA
Birnboim, H. C., & Doly, J. (1979) · Nucleic Acids Research · doi:10.1093/nar/7.6.1513 · Cited by 14,686
[21] Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction
Mullis, K. B., & Faloona, F. A. (1987) · Methods in Enzymology · doi:10.1016/0076-6879(87)55023-6 · Cited by 5,694
Kreger, B. E., Craven, D. E., & McCabe, W. R. (1980) · The American Journal of Medicine · doi:10.1016/0002-9343(80)90102-3 · Cited by 1,314
Weinstein, M. P., Reller, L. B., Murphy, J. R., & Lichtenstein, K. A. (1983) · Clinical Infectious Diseases · doi:10.1093/clinids/5.1.35 · Cited by 751
McGowan, J. E., Barnes, M. W., & Finland, M. (1975) · Journal of Infectious Diseases · doi:10.1093/infdis/132.3.316 · Cited by 498
Murray, B. E., Singh, K. V., Heath, J. D., Sharma, B. R., & Weinstock, G. M. (1990) · Journal of Clinical Microbiology · doi:10.1128/jcm.28.9.2059-2063.1990 · Cited by 495
Weinstein, M. P., Murphy, J. R., Reller, L. B., & Lichtenstein, K. A. (1983) · Clinical Infectious Diseases · doi:10.1093/clinids/5.1.54 · Cited by 472
Geoffroy, C., Gaillard, J. L., Alouf, J. E., & Berche, P. (1987) · Infection and Immunity · doi:10.1128/iai.55.7.1641-1646.1987 · Cited by 371
Reduced virulence of a defined pneumolysin-negative mutant of Streptococcus pneumoniae
Berry, A. M., Yother, J., Briles, D. E., Hansman, D., & Paton, J. C. (1989) · Infection and Immunity · doi:10.1128/iai.57.7.2037-2042.1989 · Cited by 328
Enterococcal bacteremia: clinical features, the risk of endocarditis, and management.
Maki, D. G., & Agger, W. A. (1988) · PubMed · Cited by 328
Recognition of Group D Streptococcal Species of Human Origin by Biochemical and Physiological Tests
Facklam, R. R. (1972) · Applied Microbiology · doi:10.1128/aem.23.6.1131-1139.1972 · Cited by 317
Ferretti, J. J., Gilmore, K. S., & Courvalin, P. (1986) · Journal of Bacteriology · doi:10.1128/jb.167.2.631-638.1986 · Cited by 301
Nosocomial Infection by Gentamicin-Resistant Streptococcus faecalis: An Epidemiologic Study
ZERVOS, M. J., KAUFFMAN, C. A., THERASSE, P. M., BERGMAN, A. G., MIKESELL, T. S., & SCHABERG, D. R. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-5-687 · Cited by 261
Murray, B. E., & Mederski-Samaroj, B. (1983) · Journal of Clinical Investigation · doi:10.1172/jci111042 · Cited by 253
Hemolysin of Streptococcus faecalis subspecies zymogenes contributes to virulence in mice
Ike, Y., Hashimoto, H., & Clewell, D. B. (1984) · Infection and Immunity · doi:10.1128/iai.45.2.528-530.1984 · Cited by 240
High-Level Resistance to Gentamicin in Clinical Isolates of Enterococci
Mederski-Samoraj, B. D., & Murray, B. E. (1983) · Journal of Infectious Diseases · doi:10.1093/infdis/147.4.751 · Cited by 213
Johnson, J. R., Moseley, S. L., Roberts, P. L., & Stamm, W. E. (1988) · Infection and Immunity · doi:10.1128/iai.56.2.405-412.1988 · Cited by 199
Ike, Y., Hashimoto, H., & Clewell, D. B. (1987) · Journal of Clinical Microbiology · doi:10.1128/jcm.25.8.1524-1528.1987 · Cited by 197
HOSPITAL-ACQUIRED INFECTIONS I. SURVEILLANCE IN A UNIVERSITY HOSPITAL
WENZEL, R. P., OSTERMAN, C. A., HUNTING, K. J., & GWALTNEY, J. M. (1976) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112223 · Cited by 186
High-level, plasmid-borne resistance to gentamicin in Streptococcus faecalis subsp. zymogenes
Horodniceanu, T., Bougueleret, L., El-Solh, N., Bieth, G., & Delbos, F. (1979) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.16.5.686 · Cited by 185
Enterococcal Bacteremia Clinical Implications and Determinants of Death
GARRISON, R. N., FRY, D. E., BERBERICH, S., & POLK, H. C. (1982) · Annals of Surgery · doi:10.1097/00000658-198207000-00010 · Cited by 166
Treatment of Streptomycin-Susceptible and Streptomycin-Resistant Enterococcal Endocarditis
WILSON, W. R., WILKOWSKE, C. J., WRIGHT, A. J., SANDE, M. A., & GERACI, J. E. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-100-6-816 · Cited by 159
Gatell, J. M., Trilla, A., Latorre, X., Almela, M., Mensa, J., Moreno, A., Miró, J. M., Martínez, J. A., de Anta, M. T. J., Soriano, E., et al. (1988) · Clinical Infectious Diseases · doi:10.1093/clinids/10.1.203 · Cited by 150
Zervos, M., Dembinski, S., Mikesell, T. S., et al. (1986) · The Journal of Infectious Diseases · doi:10.1093/infdis/153.6.1075 · Cited by 146
Hospital stay and mortality attributed to nosocomial enterococcal bacteremia: A controlled study
Landry, S. L., Kaiser, D. L., & Wenzel, R. P. (1989) · American Journal of Infection Control · doi:10.1016/0196-6553(89)90001-1 · Cited by 139
Mandell, G. L. (1970) · Archives of Internal Medicine · doi:10.1001/archinte.1970.00310020064005 · Cited by 138
Prevalence of high-level resistance to aminoglycosides in clinical isolates of enterococci.
Rc, M., Wennersten, C. B., Medrek, T. F., et al. (1970) · PubMed · Cited by 128
Plasmid-mediated resistance to aminocyclitol antibiotics in group D streptococci
Courvalin, P. M., Carlier, C., & Collatz, E. (1980) · Journal of Bacteriology · doi:10.1128/jb.143.2.541-551.1980 · Cited by 119
Use of streptomycin in the treatment of bacterial endocarditis
Hunter, T. H. (1947) · The American Journal of Medicine · doi:10.1016/0002-9343(47)90088-0 · Cited by 119
Enterococcal Bacteremia: Analysis of 75 Episodes
Gullberg, R. M., Homann, S. R., & Phair, J. (1989) · Clinical Infectious Diseases · doi:10.1093/clinids/11.1.74 · Cited by 114
Effects of and Toxins from Clostridium perfringens on Human Polymorphonuclear Leukocytes
Stevens, D. L., Mitten, J. Q., & Henry, C. (1987) · The Journal of Infectious Diseases · doi:10.1093/infdis/156.2.324 · Cited by 88
'Breakthrough' Enterococcal Septicemia in Surgical Patients: 19 Cases and a Review of the Literature
Dougherty, S. H. (1983) · Archives of Surgery · doi:10.1001/archsurg.1983.01390020076013 · Cited by 77
Molecular characterization of the Enterococcus faecalis cytolysin activator
Segarra, R. A., Booth, M. C., Morales, D. A., Huycke, M. M., & Gilmore, M. S. (1991) · Infection and Immunity · doi:10.1128/iai.59.4.1239-1246.1991 · Cited by 75
Self-citationMurray, B. E., Tsao, J., & Panida, J. (1983) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.23.6.799 · Cited by 68
Bryan, L. E. (1984) · Elsevier eBooks · doi:10.1016/b978-0-12-138120-2.50013-7 · Cited by 67
Bacteriocin (Hemolysin) of Streptococcus zymogenes
Basinger, S. F., & Jackson, R. W. (1968) · Journal of Bacteriology · doi:10.1128/jb.96.6.1895-1902.1968 · Cited by 59
A descriptive study of nosocomial bacteremias at The Johns Hopkins Hospital, 1968--1974.
Spengler, R., Greenough, W. B., & Pd, S. (1978) · PubMed · Cited by 56
Nachamkin, I., Axelrod, P. I., Talbot, G. H., et al. (1988) · Journal of Clinical Microbiology · doi:10.1128/jcm.26.7.1287-1291.1988 · Cited by 54
TRANSFERABLE RESISTANCE AND AMINOGLYCOSIDE-MODIFYING ENZYMES IN ENTEROCOCCI
Chen, H. Y., & Williams, J. D. (1985) · Journal of Medical Microbiology · doi:10.1099/00222615-20-2-187 · Cited by 41
Enterococcal Burn Sepsis: A Highly Lethal Complication in Severely Burned Patients
Jones, W. G. (1986) · Archives of Surgery · doi:10.1001/archsurg.1986.01400060043004 · Cited by 33
Laboratory detection of high-level aminoglycoside-aminocyclitol resistance in Enterococcus spp
Spiegel, C. A. (1988) · Journal of Clinical Microbiology · doi:10.1128/jcm.26.11.2270-2274.1988 · Cited by 31
Self-citationRisk Factors for Acquisition of Gentamicin-Resistant Enterococci
Axelrod, P. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.149.6.1397 · Cited by 30
Ikeda, D. P., Barry, A. L., & Andersen, S. (1984) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/0732-8893(84)90027-0 · Cited by 25
Jackson, R. W. (1971) · Journal of Bacteriology · doi:10.1128/jb.105.1.156-159.1971 · Cited by 24
Characterization of the A Component ofStreptococcus zymogenesLysin
Granato, P. A., & Jackson, R. W. (1971) · Journal of Bacteriology · doi:10.1128/jb.107.2.551-556.1971 · Cited by 22
Spiegel, C. A., & Huycke, M. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.1989.00390080123026 · Cited by 20
Self-citationPurification and Characterization of the L Component of Streptococcus zymogenes Lysin
Granato, P. A., & Jackson, R. W. (1971) · Journal of Bacteriology · doi:10.1128/jb.108.2.804-808.1971 · Cited by 19
Molecular epidemiology of nosocomial, moltiply aminoglycoside resistant Enterococcus faecalis
Weems, J. J., Lowrance, J. H., Baddour, L. M., et al. (1989) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/24.2.121 · Cited by 17
Cited by
The role and application of enterococci in food and health
Foulquié Moreno, M. R., Sarantinopoulos, P., Tsakalidou, E., & De Vuyst, L. (2006) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2005.06.026 · Cited by 1,080
Jett, B. D., Huycke, M. M., & Gilmore, M. S. (1994) · Clinical Microbiology Reviews · doi:10.1128/cmr.7.4.462 · Cited by 820
Self-citationDifferent drugs for bad bugs: antivirulence strategies in the age of antibiotic resistance
Dickey, S. W., Cheung, G. Y. C., & Otto, M. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.23 · Cited by 799
Enterococci as probiotics and their implications in food safety
Franz, C. M. A. P., Huch, M., Abriouel, H., Holzapfel, W., & Gálvez, A. (2011) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2011.08.014 · Cited by 788
Goldmann, D. A. (1996) · JAMA · doi:10.1001/jama.1996.03530270074035 · Cited by 753
Metadata
- Authors
- Huycke, M. M., Spiegel, C. A., & Gilmore, M. S.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 1991-08
- Volume
- 35
- Issue
- 8
- Pages
- 1626-1634
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2038030292
- Cited by
- 283
- References
- 49
- FWCI
- 5.83
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.